Status:
COMPLETED
Early Goal Directed Therapy in Cardiac Surgery
Lead Sponsor:
Khon Kaen University
Conditions:
Postoperative Outcome
ICU Stay
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Early goal directed therapy (EGDT) based on information from arterial waveform derived cardiac output (APCO) FloTrac/EV1000 system has been proved to improve postoperative outcomes in patients undergo...
Detailed Description
Objective: To compare postoperative clinical outcome in adult patients undergoing cardiac surgery. Primary outcome: Postoperative inotropic/vasoactive drugs reqirement. Secondary outcome: ICU stay. ...
Eligibility Criteria
Inclusion
- 18-80 years old
- Patient has ischemic or valvular heart disease
- Scheduled for elective cardiac surgery
- New York Heart Association (NYHA) or American society of Anesthesiology (ASA) classification I-III
- Body mass index (BMI) 18-24 kg/m2
- Provided informed consent before surgery
Exclusion
- Scheduled for emergency or redo surgery
- Difficulty (or contraindication to) placing a central venous catheter
- Inability to cooperate (e.g. mental disorder, disturbance of consciousness, mental retardation)
- Presence of blood-borne infectious disease (e.g. syphilis, acquired immunodeficiency
Key Trial Info
Start Date :
January 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2020
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04292951
Start Date
January 1 2020
End Date
July 1 2020
Last Update
September 2 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine, Khon Kaen University
Khon Kaen, Thailand, 40002